The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene Delivery
Abstract
We have examined the complement-activating properties of synthetic cationic molecules and their complexes with DNA. Commonly used gene delivery vehicles include complexes of DNA with polylysine of various chain lengths, transferrin-polylysine, a fifth-generation poly(amidoamine) (PAMAM) dendrimer, poly(ethyleneimine), and several cationic lipids (DOTAP, DC-Chol/DOPE, DOGS/DOPE, and DOTMA/DOPE). These agents activate the complement system to varying extents. Strong complement activation is seen with long-chain polylysines, the dendrimer, poly(ethyleneimine), and DOGS (half-maximal at about 3 μM amine content in the assay used). Compared to these compounds, the other cationic lipids (in liposome formulations) are weak activators of the complement system (half-maximal ≈ 50–100 μM positive charge in assay). Complement activation by polylysine is strongly dependent on the chain length. Short-chain oligolysines are comparable to cationic lipids in their activation of complement. Incubation of these compounds with DNA to form complexes reduces complement activation in virtually all cases. The degree of complement activation by DNA complexes is strongly dependent on the ratio of polycation and DNA (expressed as the charge ratio) for polylysine, dendrimer, poly(ethyleneimine), and DOGS. To a lesser degree, charge ratio also influences complement activation by monovalent cationic lipid–DNA complexes. For polylysine–DNA complexes, complement activation can be considerably reduced by modifying the surface of preformed DNA complexes with polyethyleneglycol (half-maximal ≈ 20 μM amine content). The data suggests that, by appropriate formulation of DNA complexes, complement activation can be minimized or even avoided. These findings should facilitate the search for DNA complex formulations appropriate for reproducible intravenous gene delivery. Successful gene delivery upon intravenous administration of DNA complexes has been reported in several cases. However, there is considerable variability and poor reproducibility with such systems. The variability makes it difficult to understand which of the multitude of factors that impact this mode of gene delivery limits the reproducibility. Limiting parameters may include the stability of DNA complexes in blood and their interaction with blood components. Such interactions may limit the half-life and targetability of DNA complexes. The components of the complement system are likely candidates to interact with (opsonize) intravenously administered DNA complexes. To find out whether DNA complexes activate the complement system, we have examined a number of synthetic cationic molecules frequently used in gene delivery and their complexes with DNA for their complement-activating properties. The results indicate that complement activation is a potential limiting factor for gene delivery by synthetic DNA complexes. Furthermore, appropriate formulation of DNA complexes can minimize or avoid complement activation and possibly other interactions with blood components.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
Haensler, J., & Szoka, F. C. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a012 · Cited by 1,207
Self-citationSterically stabilized liposomes
Woodle, M. C., & Lasic, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90038-c · Cited by 954
Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.
Behr, J. P., Demeneix, B., Loeffler, J. P., & Perez-Mutul, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6982 · Cited by 719
Liposomes for the sustained drug release in vivo
Blume, G., & Cevc, G. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90440-y · Cited by 698
Transferrin-polycation conjugates as carriers for DNA uptake into cells.
Wagner, E., Zenke, M., Cotten, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3410 · Cited by 655
Self-citationReceptor-mediated gene delivery and expression in vivo.
Wu, G. Y., & Wu, C. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68081-0 · Cited by 635
The Classical Complement Pathway: Activation and Regulation of the First Complement Component
Cooper, N. R. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60340-5 · Cited by 510
Adenovirus–mediated in vivo gene transfer and expression in normal rat liver
Jaffe, H. A., Danel, C., Longenecker, G., Metzger, M., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-372 · Cited by 449
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Dendron-Mediated Self-Assembly, Disassembly, and Self-Organization of Complex Systems
Rosen, B. M., Wilson, C. J., Wilson, D. A., Peterca, M., Imam, M. R., & Percec, V. (2009) · Chemical Reviews · doi:10.1021/cr900157q · Cited by 1,204
Poly(ethylenimine) and its role in gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00090-5 · Cited by 1,199
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Self-citationDendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
Bulte, J. W. M., Douglas, T., Witwer, B., Zhang, S.-C., Strable, E., Lewis, B. K., Zywicke, H., Miller, B., van Gelderen, P., Moskowitz, B. M., et al. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1141 · Cited by 1,027
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 983
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Trends and Developments in Liposome Drug Delivery Systems
Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 907
Cationic Polymer Based Gene Delivery Systems
De Smedt, S. C., Demeester, J., & Hennink, W. E. (2000) · Pharmaceutical Research · doi:10.1023/a:1007548826495 · Cited by 884
Neu, M., Fischer, D., & Kissel, T. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.773 · Cited by 866
Effects of nanomaterial physicochemical properties on in vivo toxicity
Aillon, K. L., Xie, Y., El-Gendy, N., Berkland, C. J., & Forrest, M. L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.010 · Cited by 811
Kunath, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00076-2 · Cited by 809
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J.-P. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 769
Different behavior of branched and linear polyethylenimine for gene deliveryin vitro andin vivo
Wightman, L., Kircheis, R., R�ssler, V., Carotta, S., Ruzicka, R., Kursa, M., & Wagner, E. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.187 · Cited by 697
Self-citationDesign and gene delivery activity of modified polyethylenimines
Kircheis, R., Wightman, L., & Wagner, E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00202-2 · Cited by 651
Self-citationGene delivery by lipoplexes and polyplexes
Tros de Ilarduya, C., Sun, Y., & Düzgüneş, N. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.019 · Cited by 627
Kraft, J. C., Freeling, J. P., Wang, Z., & Ho, R. J. Y. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23773 · Cited by 606
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 600
Self-citationNonviral Vectors in the New Millennium: Delivery Barriers in Gene Transfer
Nishikawa, M., & Huang, L. (2001) · Human Gene Therapy · doi:10.1089/104303401750195836 · Cited by 574
Ogris, M., Steinlein, P., Kursa, M., Mechtler, K., Kircheis, R., & Wagner, E. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300745 · Cited by 571
Self-citationKunzmann, A., Andersson, B., Thurnherr, T., Krug, H., Scheynius, A., & Fadeel, B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.007 · Cited by 527
Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery
Schaffer, D. V., Fidelman, N. A., Dan, N., & Lauffenburger, D. A. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000305)67:5<598::aid-bit10>3.0.co;2-g · Cited by 524
Polyester Dendritic Systems for Drug Delivery Applications: In Vitro and In Vivo Evaluation
Padilla De Jesús, O. L., Ihre, H. R., Gagne, L., Fréchet, J. M. J., & Szoka, F. C. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010103m · Cited by 507
Self-citationPolylysine-based transfection systems utilizing receptor-mediated delivery
Zauner, W., Ogris, M., & Wagner, E. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00110-5 · Cited by 504
Self-citationHUNTER, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.008 · Cited by 456
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454
Breaking up the correlation between efficacy and toxicity for nonviral gene delivery
Breunig, M., Lungwitz, U., Liebl, R., & Goepferich, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703882104 · Cited by 443
Key issues in non-viral gene delivery
Pouton, C. W., & Seymour, L. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00048-9 · Cited by 440
Nonviral gene delivery: What we know and what is next
Gao, X., Kim, K.-S., & Liu, D. (2007) · The AAPS Journal · doi:10.1208/aapsj0901009 · Cited by 431
Polymer systems for gene delivery—Past, present, and future
Wong, S. Y., Pelet, J. M., & Putnam, D. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.007 · Cited by 427
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419
Dash, P. R., Read, M. L., Barrett, L. B., Wolfert, M. A., & Seymour, L. W. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300843 · Cited by 386
Development of Biomaterials for Gene Therapy
Han, S.-O., Mahato, R. I., Sung, Y. K., & Kim, S. W. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0142 · Cited by 384
Ylä-Herttuala, S., & Martin, J. F. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04180-x · Cited by 375
The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery
Plank, C., Schillinger, U., Scherer, F., Bergemann, C., Rémy, J.-S., Krötz, F., Anton, M., Lausier, J., & Rosenecker, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.082 · Cited by 369
Self-citationPolymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Santa Chalarca, C. F., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 365
Cationic lipid–DNA complexes in gene delivery: from biophysics to biological applications
Pedroso de Lima, M. C., Simões, S., Pires, P., Faneca, H., & Düzgüneş, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00110-7 · Cited by 365
Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
Kircheis, R., Kichler, A., Wallner, G., Kursa, M., Ogris, M., Felzmann, T., Buchberger, M., & Wagner, E. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300418 · Cited by 359
Self-citationPolycation-based DNA complexes for tumor-targeted gene deliveryin vivo
Kircheis, R., Schüller, S., Brunner, S., Ogris, M., Heider, K.-H., Zauner, W., & Wagner, E. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199903/04)1:2<111::aid-jgm22>3.0.co;2-y · Cited by 356
Self-citationKircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rössler, V, Kursa, M., & Wagner, E. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301351 · Cited by 350
Self-citationPolyethylenimine (PEI) in gene therapy: Current status and clinical applications
Casper, J., Schenk, S. H., Parhizkar, E., Detampel, P., Dehshahri, A., & Huwyler, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.001 · Cited by 340
Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 321
Self-citationMagnetically enhanced nucleic acid delivery. Ten years of magnetofection—Progress and prospects
Plank, C., Zelphati, O., & Mykhaylyk, O. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.08.002 · Cited by 316
Self-citationThe use of PAMAM dendrimers in the efficient transfer of genetic material into cells
Eichman, J. D., Bielinska, A. U., Kukowska-Latallo, J. F., & Baker, J. R. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00273-x · Cited by 313
Zelphati, O., Uyechi, L. S., Barron, L. G., & Szoka, F. C. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00169-0 · Cited by 310
Self-citationPolymers for siRNA Delivery: Inspired by Viruses to be Targeted, Dynamic, and Precise
Wagner, E. (2012) · Accounts of Chemical Research · doi:10.1021/ar2002232 · Cited by 308
Self-citationKonstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H., Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1255 · Cited by 298
Biomedical application of functional polymers
Jagur-Grodzinski, J. (1999) · Reactive and Functional Polymers · doi:10.1016/s1381-5148(98)00054-6 · Cited by 297
Erbacher, P., Bettinger, T., Belguise-Valladier, P., Zou, S., Coll, J.-L., Behr, J.-P., & Remy, J.-S. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199905/06)1:3<210::aid-jgm30>3.0.co;2-u · Cited by 295
Pouton, C. W., & Seymour, L. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00133-2 · Cited by 291
Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development
Drummond, D. C., Noble, C. O., Hayes, M. E., Park, J. W., & Kirpotin, D. B. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21358 · Cited by 289
Karmali, P. P., & Chaudhuri, A. (2007) · Medicinal Research Reviews · doi:10.1002/med.20090 · Cited by 289
In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation
Bulte, J. W. M., Duncan, I. D., & Frank, J. A. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200208000-00001 · Cited by 288
Cationic liposomes for gene delivery
Simões, S., Filipe, A., Faneca, H., Mano, M., Penacho, N., Düzgünes, N., & Pedroso de Lima, M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.237 · Cited by 285
Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing Nanoparticles
Bartlett, D. W., & Davis, M. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603539 · Cited by 283
Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver
Kwoh, D. Y., Coffin, C. C., Lollo, C. P., Jovenal, J., Banaszczyk, M. G., Mullen, P., Phillips, A., Amini, A., Fabrycki, J., Bartholomew, R. M., et al. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00274-7 · Cited by 276
Ziegler, A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.005 · Cited by 255
Xu, L., & Anchordoquy, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22243 · Cited by 209
Wen, J., Weinhart, M., Lai, B., Kizhakkedathu, J., & Brooks, D. E. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.067 · Cited by 158
Metadata
- Authors
- Plank, C., Mechtler, K., Szoka, F. C., & Wagner, E.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1996-08
- Volume
- 7
- Issue
- 12
- Pages
- 1437-1446
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2003904826
- Cited by
- 583
- References
- 38
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.